480 related articles for article (PubMed ID: 25175933)
1. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
[TBL] [Abstract][Full Text] [Related]
3. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
4. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
5. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
6. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
Eilber FC; Rosen G; Eckardt J; Forscher C; Nelson SD; Selch M; Dorey F; Eilber FR
J Clin Oncol; 2001 Jul; 19(13):3203-9. PubMed ID: 11432887
[TBL] [Abstract][Full Text] [Related]
7. Modified staging system for extremity soft tissue sarcomas.
Ramanathan RC; A'Hern R; Fisher C; Thomas JM
Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
9. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas.
Manoso MW; Frassica DA; Deune EG; Frassica FJ
J Surg Oncol; 2005 Sep; 91(3):153-8. PubMed ID: 16118773
[TBL] [Abstract][Full Text] [Related]
11. Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas.
Khoja H; Griffin A; Dickson B; Wunder J; Ferguson P; Howarth D; Kandel R
Arch Pathol Lab Med; 2013 Dec; 137(12):1774-9. PubMed ID: 24283858
[TBL] [Abstract][Full Text] [Related]
12. Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-up.
Toulmonde M; Le Cesne A; Mendiboure J; Blay JY; Piperno-Neumann S; Chevreau C; Delcambre C; Penel N; Terrier P; Ranchère-Vince D; Lae M; Le Guellec S; Michels JJ; Robin YM; Bellera C; Italiano A
Cancer; 2014 Oct; 120(19):3003-6. PubMed ID: 24942887
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.
Singer S; Corson JM; Gonin R; Labow B; Eberlein TJ
Ann Surg; 1994 Feb; 219(2):165-73. PubMed ID: 8129487
[TBL] [Abstract][Full Text] [Related]
14. Histologic Response to Neoadjuvant Therapy Is Not Predictive of Favorable Outcomes in High-grade Pleomorphic Soft Tissue Sarcoma.
Cates JMM
Am J Surg Pathol; 2019 Apr; 43(4):564-572. PubMed ID: 30628925
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler M; Gosheger G; Jobke B; Reichardt P; Tunn PU
Br J Cancer; 2015 Feb; 112(3):455-60. PubMed ID: 25535732
[TBL] [Abstract][Full Text] [Related]
16. Soft-tissue sarcomas of the chest wall: prognostic factors.
Gross JL; Younes RN; Haddad FJ; Deheinzelin D; Pinto CA; Costa ML
Chest; 2005 Mar; 127(3):902-8. PubMed ID: 15764774
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant radiation therapy for soft tissue sarcoma of the extremities: analysis of local control according to volume and dose].
Milbéo Y; Kantor G; Laharie H; Lagarde P; Stoeckle E; Bonichon F; Thomas L; Brouste V; Bui BN
Cancer Radiother; 2005 Sep; 9(5):293-303. PubMed ID: 16005654
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of margin width for extremity and trunk sarcoma.
McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in sarcomas of the soft tissues].
Saccani Jotti G; Banadonna G
Acta Biomed Ateneo Parmense; 1986; 57(5-6):187-201. PubMed ID: 2955624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
